Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report

Li, D; Que, YM; Ding, SN; Hu, G; Wang, W; Mao, X; Wang, Y; Li, CR; Huang, L; Zhou, JF; Zhang, W; Xiao, M

Zhang, W; Xiao, M (通讯作者)，Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Hubei, Peoples R China.;Zhang, W; Xiao, M (通讯作者)，Immunotherapy Res, Immunotherapy Res Ctr Hematol Dis Hubei Prov, Wuhan, Hubei, Peoples R China.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022; 10 (9):

Abstract

B cell maturation antigen (BCMA)-directed CAR-T cell therapy is a disruptive approach for treating relapsed/ refractory multiple myeloma (R/R MM); how......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索